Stay updated on Fruquintinib and Raltitrexed vs Fruquintinib Monotherapy Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib and Raltitrexed vs Fruquintinib Monotherapy Clinical Trial page.

Latest updates to the Fruquintinib and Raltitrexed vs Fruquintinib Monotherapy Clinical Trial page
- Check4 days agoChange DetectedThe record presents a Phase II study comparing fruquintinib plus raltitrexed with fruquintinib alone for advanced colorectal cancer, including its eligibility criteria, treatment arms, outcomes, and study location.SummaryDifference47%

- Check11 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA site-wide NIH notice announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition period. The footer revision identifier advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe site revision label changes from v3.7.0 to v3.7.1. The page remains a 403 error page without study details.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content. This makes the study information on this page inaccessible to users.SummaryDifference18%

- Check60 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.6 to v3.7.0, indicating a platform release; this update appears as part of the page’s revision history and does not modify the study details.SummaryDifference0.1%

Stay in the know with updates to Fruquintinib and Raltitrexed vs Fruquintinib Monotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Raltitrexed vs Fruquintinib Monotherapy Clinical Trial page.